Literature DB >> 11018537

The Yersinia Ser/Thr protein kinase YpkA/YopO directly interacts with the small GTPases RhoA and Rac-1.

C Barz1, T N Abahji, K Trülzsch, J Heesemann.   

Abstract

Pathogenic bacteria of the genus Yersinia counteract host defense by interfering with eukaryotic signal transduction pathways. YpkA of Yersinia pseudotuberculosis shares significant homology with eukaryotic Ser/Thr protein kinases, is translocated into the host cell and has been shown to be an essential virulence factor in a mouse infection model. In this study, we identify the small GTPases RhoA and Rac-1 as eukaryotic binding partners of YpkA and its homolog YopO of Yersinia enterocolitica. We demonstrate that the interaction is independent of phosphorylation of YpkA and nucleotide loading state of the GTPases. The interaction with RhoA and Rac-1 might provide an important clue to how YpkA interferes with eukaryotic signaling on a molecular level.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11018537     DOI: 10.1016/s0014-5793(00)02045-7

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  33 in total

1.  Recombinant Yersinia YopT leads to uncoupling of RhoA-effector interaction.

Authors:  I Sorg; U M Goehring; K Aktories; G Schmidt
Journal:  Infect Immun       Date:  2001-12       Impact factor: 3.441

2.  The C terminus of YopT is crucial for activity and the N terminus is crucial for substrate binding.

Authors:  Isabel Sorg; Claudia Hoffmann; Juergen Dumbach; Klaus Aktories; Gudula Schmidt
Journal:  Infect Immun       Date:  2003-08       Impact factor: 3.441

3.  Role of Rac1 in Escherichia coli K1 invasion of human brain microvascular endothelial cells.

Authors:  Rajyalakshmi S Rudrabhatla; Suresh K Selvaraj; Nemani V Prasadarao
Journal:  Microbes Infect       Date:  2005-09-16       Impact factor: 2.700

4.  The discovery of SycO highlights a new function for type III secretion effector chaperones.

Authors:  Michel Letzelter; Isabel Sorg; Luís Jaime Mota; Salome Meyer; Jacqueline Stalder; Mario Feldman; Marina Kuhn; Isabelle Callebaut; Guy R Cornelis
Journal:  EMBO J       Date:  2006-06-22       Impact factor: 11.598

5.  Sequestering of Rac by the Yersinia effector YopO blocks Fcgamma receptor-mediated phagocytosis.

Authors:  Eleanor Groves; Katrin Rittinger; Marlise Amstutz; Sara Berry; David W Holden; Guy R Cornelis; Emmanuelle Caron
Journal:  J Biol Chem       Date:  2009-11-19       Impact factor: 5.157

6.  Redundant and Cooperative Roles for Yersinia pestis Yop Effectors in the Inhibition of Human Neutrophil Exocytic Responses Revealed by Gain-of-Function Approach.

Authors:  Amanda R Pulsifer; Aruna Vashishta; Shane A Reeves; Jennifer K Wolfe; Samantha G Palace; Megan K Proulx; Jon Goguen; Sobha R Bodduluri; Bodduluri Haribabu; Silvia M Uriarte; Matthew B Lawrenz
Journal:  Infect Immun       Date:  2020-02-20       Impact factor: 3.441

7.  Threonine phosphorylation prevents promoter DNA binding of the Group B Streptococcus response regulator CovR.

Authors:  Wan-Jung Lin; Don Walthers; James E Connelly; Kellie Burnside; Kelsea A Jewell; Linda J Kenney; Lakshmi Rajagopal
Journal:  Mol Microbiol       Date:  2009-01-23       Impact factor: 3.501

8.  Intranasal inoculation of mice with Yersinia pseudotuberculosis causes a lethal lung infection that is dependent on Yersinia outer proteins and PhoP.

Authors:  Michael L Fisher; Cynthia Castillo; Joan Mecsas
Journal:  Infect Immun       Date:  2006-10-30       Impact factor: 3.441

9.  Staphylococcal PknB as the first prokaryotic representative of the proline-directed kinases.

Authors:  Malgorzata Miller; Stefanie Donat; Sonja Rakette; Thilo Stehle; Thijs R H M Kouwen; Sander H Diks; Annette Dreisbach; Ewoud Reilman; Katrin Gronau; Dörte Becher; Maikel P Peppelenbosch; Jan Maarten van Dijl; Knut Ohlsen
Journal:  PLoS One       Date:  2010-02-04       Impact factor: 3.240

Review 10.  Deubiquitinating enzymes as promising drug targets for infectious diseases.

Authors:  Bindu Nanduri; Akamol E Suvarnapunya; Malabi Venkatesan; Mariola J Edelmann
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.